Page last updated: 2024-10-23

bepridil and Coronary Artery Vasospasm

bepridil has been researched along with Coronary Artery Vasospasm in 3 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Research Excerpts

ExcerptRelevanceReference
"Bepridil, a new anti-anginal drug, was given in a daily dosage of 400 to 600 mg to twenty patients with unstable angina pectoris."2.65[A clinical trial of the effectiveness and tolerance of bepridil in unstable angina pectoris]. ( Amat, G; Boch, C; Colonna, D; Curnier, JM, 1982)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kazatani, T1
Higaki, A1
Tanaka, Y1
Kawada, Y1
Amat, G1
Boch, C1
Curnier, JM1
Colonna, D1
Delarrat, M1
Vigreux, A1
Garcia, A1
Gorny, P1
Passelecq, J1

Trials

1 trial available for bepridil and Coronary Artery Vasospasm

ArticleYear
[A clinical trial of the effectiveness and tolerance of bepridil in unstable angina pectoris].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1982, Dec-09, Volume: 58, Issue:45

    Topics: Adult; Aged; Angina Pectoris, Variant; Bepridil; Clinical Trials as Topic; Coronary Vasospasm; Femal

1982

Other Studies

2 other studies available for bepridil and Coronary Artery Vasospasm

ArticleYear
The potential effect of bepridil on vasospastic angina in atrial fibrillation patients undergoing catheter ablation.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2023, Volume: 66, Issue:7

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Catheter Ablation; Coronary Vasospasm; Humans

2023
[Correction by a calcium inhibitor of a coronary spasm occurring during aortocoronary bypass].
    Annales francaises d'anesthesie et de reanimation, 1984, Volume: 3, Issue:1

    Topics: Bepridil; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Vasospasm; Electrocardiography;

1984